Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Alzamend Neuro Inc
ALZNCurrent price
1.6 USD
+0.03 USD (+1.91%)
Last closed
1.6 USD
Company
www.alzamend.com
ISIN
US02262M3088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
6 457 499 USD
Yield for 12 month
-94.92 %
1Y
3Y
5Y
10Y
15Y
ALZN
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company has partnership agreement with Massachusetts General Hospital for the Phase II clinical trial of AL001. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia. Address: 3480 Peachtree Road NE, Atlanta, GA, United States, 30326
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
50 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+76 110 USD
Current Year
-50 740 USD
Last Year
-23 066 USD
Current Quarter
–
Last Quarter
+63 425 USD
Key Figures ALZN
1 year
3 years
5 years
10 years
EBITDA
-7 323 379 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-214.47 %
PEG Ratio
–
Return On Equity TTM
-4408.31 %
Wall Street Target Price
50 USD
Revenue TTM
–
Book Value
-1.41 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-142.87 USD
Diluted Eps TTM
-142.87 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALZN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
16.07.2024
Dividend Date
–
Stock Valuation ALZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.1332
Price Book MRQ
7.2255
Financials ALZN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALZN
For 52 weeks
1.4 USD
33.75 USD
50 Day MA
2.42 USD
Shares Short Prior Month
67 928
200 Day MA
6.23 USD
Short Ratio
0.02
Shares Short
69 806
Short Percent
1.89 %
BeatStart